ResMed Inc. vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.69. The key difference: ResMed Inc. pays a 1.21% dividend while Vanguard Global ex-US Real Estate Index Fd ETF pays none, and Vanguard Global ex-US Real Estate Index Fd ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | VNQI | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | — |
52-Week High | $293.73 | $50.76 |
52-Week Low | $182.82 | $43.26 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →